Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
New York Governor Announces PrEP Assistance Program

New York Governor Andrew Cuomo announced last week a new pre-exposure prophylaxis assistance program that proponents say will help to end the AIDS epidemic in the state by 2020. The country's first-of-its-kind program will help at-risk groups, including gay and bi men and transgender women, obtain testing, medication, and counseling.

Published
Less than 1 hour ago
From
HIVPlusMag
Maligned Study on Gay Unions Is Shaking Trust

In 2012, as same-sex marriage advocates were working to build support in California, Michael LaCour, a political science researcher at the University of California, Los Angeles, asked a critical question: Can canvassers with a personal stake in an issue — in this case, gay men and women — actually sway voters’ opinions in a lasting way? Last week, their finding that gay canvassers were in fact powerfully persuasive with people who had voted against same-sex marriage — published in December in Science, one of the world’s leading scientific journals — collapsed amid accusations that Mr. LaCour had misrepresented his study methods and lacked the evidence to back up his findings.

Published
1 hour ago
From
New York Times
WHO Advances Research and Development Financing Effort; Global R&D Observatory To Launch In January

World Health Organization members in committee this week took note of a report by the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), which was set up to find ways to fund research on diseases afflicting poor populations which have little market incentive for the private sector. The report included a proposal for a voluntary pooled fund that would focus on the development of effective and affordable health technologies for such neglected diseases.

Published
1 hour ago
From
Intellectual Property Watch
World Health Assembly: Experts discuss delinking drug R&D costs from pricing to make them affordable

The problem of drug prices eating up national health budgetscame up at the annual World Health Assembly, which took place from 18-26 May. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

Published
2 hours ago
From
Intellectual Property Watch
NHS England accused of interference over hepatitis C drug

Officials at NHS England have been accused of interfering in a process to decide whether a drug which can cure Hepatitis C should be made available to patients on the health service.

Published
2 hours ago
From
Channel 4 News
Africa's health centre at the frontline of HIV research

The Africa Centre for Health and Population Studies sits in the HIV capital of the world. The sleek modern building, rising out of an otherwise rustic setting near Mtubatuba in South Africa, attracts world-class researchers looking to wage war against the resilient virus.

Published
2 hours ago
From
The Guardian
Funders' priorities and targets hindered community mobilisation and meaningful participation of sex workers in India

Two qualitative studies, investigating the implementation of a massive programme of HIV prevention through community mobilisation in India, have identified challenges to the rapid scale-up and roll-out

Published
25 May 2015
By
Roger Pebody
Achillion partners with J&J to develop hepatitis C drugs

Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.

Published
20 May 2015
From
Reuters
Is Gilead Sciences Its Own Worst Enemy?

Gilead's science is so good that it's actually destroying the company's business. Pharma companies, like most other businesses, make the bulk of their money through repeat business. Gilead, however, is doing something really no other drugmaker is doing -- namely curing patients of devastating infectious diseases.

Published
20 May 2015
From
Motley Fool
Fighting HIV where no-one admits it's a problem

For years Russia has remained remarkably silent on the challenge it faces from HIV and Aids. Now that silence has been broken by an epidemiologist who has been working in the field for more than two decades - and he calls the situation "a national catastrophe".

Published
20 May 2015
From
BBC
← First12345...480Next →

Filter by country